Norges Bank’s Eli Lilly & Co Position
Does Norges Bank own Eli Lilly & Co (LLY)? Not currently — the last reported position was 12.07M shares worth $13.0B in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$13.0B
Q4 2025
Shares
12.07M
% of Portfolio
+1.39%
Quarters Held
23
position exited
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 12.07M | $13.0B | +1.39% |
| Q2 2025 | 11.32M | $8.8B | +1.10% |
| Q1 2025 | 10.72M | $8.3B | +1.32% |
| Q4 2024 | 10.89M | $8.4B | +1.10% |
| Q3 2024 | 9.87M | $5.3B | +1.08% |
| Q2 2024 | 20.85M | $14.6B | +1.24% |
| Q1 2024 | 9.65M | $3.3B | +0.73% |
| Q4 2023 | 10.28M | $6.0B | +1.05% |
| Q3 2023 | 8.57M | $2.8B | +0.74% |
| Q2 2023 | 8.30M | $2.7B | +0.70% |
| Q4 2022 | 9.34M | $3.4B | +0.82% |
| Q3 2022 | 8.26M | $1.9B | +0.42% |
| Q2 2022 | 8.52M | $2.0B | +0.42% |
| Q1 2022 | 8.79M | $1.6B | +0.38% |
| Q3 2021 | 8.64M | $1.3B | +0.34% |
| Q2 2021 | 8.36M | $1.4B | +0.40% |
| Q1 2021 | 8.81M | $1.2B | +0.44% |
| Q3 2020 | 8.91M | $997M | +0.31% |
| Q2 2020 | 8.97M | $994M | +0.31% |
| Q1 2020 | 8.92M | $1.2B | +0.37% |
| Q3 2019 | 9.08M | $975M | +0.32% |
| Q2 2019 | 9.08M | $775M | +0.27% |
| Q1 2019 | 9.05M | $700M | +0.25% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norges Bank’s full portfolio or all institutional holders of LLY.